Inve India ▾
SISIGACHI

Sigachi Industries Q4 FY25 results (Jan–Mar 2025) and concall

Healthcare · Concall AI · Call held 30 May 2025

Sigachi Industries Limited delivered a strong Q4 and FY25, marked by robust revenue and EBITDA growth driven by its core MCC business. The company is strategically expanding MCC capacity, progressing with its CCS project, and successfully entering regulated API markets. While API revenue saw a temporary dip due to a focus on higher-margin products, the overall outlook remains positive with targets for sustained revenue growth and margin expansion, supported by operational efficiencies and diversification efforts.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

What they filed

₹ Cr · quarterly
Line itemQ2 FY25Q3 FY25Q4 FY25
Revenue109 105 114
EBITDA18 21 19
Net profit22 10 7
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.